ERVW-1 and myeloid sarcoma: It follows that the immunoreactivity observed in MS lesions stained with mAb 6A2B2 in former studies [12,16,18] and this work may indicate expression of an HERV-W Env antigen different from Syncytin-1 in MS brain lesions.